Rubius Therapeutics: Q2 Earnings Insights

Rubius Therapeutics RUBY reported its Q2 earnings results on Tuesday, August 9, 2022 at 08:00 AM.

Here's what investors need to know about the announcement.

Rubius Therapeutics beat estimated earnings by 7.55%, reporting an EPS of $-0.49 versus an estimate of $-0.53.

Revenue was down $0 from the same period last year.

Last quarter the company missed on EPS by $0.0 which was followed by a 12.93% drop in the share price the next day.

To track all earnings releases for Rubius Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.